Advocacy at a Glance 1/8/21 Advocacy at a Glance 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More 12/21/20 12/21/20 FY 21 Appropriations Provisions and COVID-19 Relief / Stimulus Provisions Related to FDA Read More Advocacy at a Glance 12/18/20 Advocacy at a Glance 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More Advocacy at a Glance 12/18/20 Advocacy at a Glance 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More Advocacy at a Glance 12/11/20 Advocacy at a Glance 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More Advocacy at a Glance 12/5/20 Advocacy at a Glance 12/5/20 CDRH Director Presents at Alliance Webinar Read More Analysis and Commentary 11/12/20 Analysis and Commentary 11/12/20 Where $40 Million Might Go for FY 21 Read More Advocacy at a Glance 11/13/20 Advocacy at a Glance 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More Advocacy at a Glance 10/31/20 Advocacy at a Glance 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More Advocacy at a Glance 9/25/20 Advocacy at a Glance 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More Advocacy at a Glance 9/18/20 Advocacy at a Glance 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More Advocacy at a Glance 9/11/20 Advocacy at a Glance 9/11/20 Alliance Webinar with CDER Postponed, Will Be Rescheduled Shortly Read More Analysis and Commentary 9/3/20 Analysis and Commentary 9/3/20 Understanding Tom Frieden's Proposed HDO Read More Advocacy at a Glance 9/4/20 Advocacy at a Glance 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More Analysis and Commentary 8/14/20 Analysis and Commentary 8/14/20 "Somehow the CR Will Pass", But When? Read More Advocacy at a Glance 8/14/20 Advocacy at a Glance 8/14/20 Party Platforms Don’t Matter, Probably Read More Analysis and Commentary 8/7/20 Analysis and Commentary 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More Advocacy at a Glance 8/7/20 Advocacy at a Glance 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Advocacy at a Glance 8/1/20 Advocacy at a Glance 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More Advocacy at a Glance 7/26/20 Advocacy at a Glance 7/26/20 FY 21 Appropriation: Qs&As Read More Older Posts
Advocacy at a Glance 1/8/21 Advocacy at a Glance 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More
12/21/20 12/21/20 FY 21 Appropriations Provisions and COVID-19 Relief / Stimulus Provisions Related to FDA Read More
Advocacy at a Glance 12/18/20 Advocacy at a Glance 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More
Advocacy at a Glance 12/18/20 Advocacy at a Glance 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More
Advocacy at a Glance 12/11/20 Advocacy at a Glance 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More
Advocacy at a Glance 12/5/20 Advocacy at a Glance 12/5/20 CDRH Director Presents at Alliance Webinar Read More
Analysis and Commentary 11/12/20 Analysis and Commentary 11/12/20 Where $40 Million Might Go for FY 21 Read More
Advocacy at a Glance 11/13/20 Advocacy at a Glance 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More
Advocacy at a Glance 10/31/20 Advocacy at a Glance 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More
Advocacy at a Glance 9/25/20 Advocacy at a Glance 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More
Advocacy at a Glance 9/18/20 Advocacy at a Glance 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More
Advocacy at a Glance 9/11/20 Advocacy at a Glance 9/11/20 Alliance Webinar with CDER Postponed, Will Be Rescheduled Shortly Read More
Analysis and Commentary 9/3/20 Analysis and Commentary 9/3/20 Understanding Tom Frieden's Proposed HDO Read More
Advocacy at a Glance 9/4/20 Advocacy at a Glance 9/4/20 Congress Expected to Pass a Continuing Resolution in September, but Key Details Remain to be Resolved Read More
Analysis and Commentary 8/14/20 Analysis and Commentary 8/14/20 "Somehow the CR Will Pass", But When? Read More
Advocacy at a Glance 8/14/20 Advocacy at a Glance 8/14/20 Party Platforms Don’t Matter, Probably Read More
Analysis and Commentary 8/7/20 Analysis and Commentary 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More
Advocacy at a Glance 8/7/20 Advocacy at a Glance 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Advocacy at a Glance 8/1/20 Advocacy at a Glance 8/1/20 House Will Pause Once It Has Completed 10 of 12 Appropriations Bills Read More
